| Product Code: ETC7638786 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Ireland`s quinolones import market in 2024 continued to be dominated by key players such as Japan, Switzerland, USA, Netherlands, and UK. Despite a high level of market concentration indicated by the HHI, the industry experienced a significant decline with a CAGR of -20.49% from 2020 to 2024. The growth rate plummeted further in 2024, showing a steep decline of -61.41%. This data suggests a challenging landscape for quinolones importers in Ireland, highlighting the need for strategic adjustments to navigate the market dynamics effectively.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Quinolones Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Quinolones Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Quinolones Market - Industry Life Cycle |
3.4 Ireland Quinolones Market - Porter's Five Forces |
3.5 Ireland Quinolones Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Ireland Quinolones Market Revenues & Volume Share, By Pathogen Type, 2021 & 2031F |
3.7 Ireland Quinolones Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Ireland Quinolones Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Ireland Quinolones Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Ireland Quinolones Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Quinolones Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Ireland |
4.2.2 Growing awareness about the effectiveness of quinolones in treating various infections |
4.2.3 Rising demand for advanced healthcare facilities and medications in the region |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines related to the use of quinolones |
4.3.2 Concerns over antibiotic resistance and side effects associated with quinolones |
5 Ireland Quinolones Market Trends |
6 Ireland Quinolones Market, By Types |
6.1 Ireland Quinolones Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Quinolones Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Ireland Quinolones Market Revenues & Volume, By Urinary Tract Infection, 2021- 2031F |
6.1.4 Ireland Quinolones Market Revenues & Volume, By Intra-Abdominal Infections, 2021- 2031F |
6.1.5 Ireland Quinolones Market Revenues & Volume, By Blood Stream Infections, 2021- 2031F |
6.1.6 Ireland Quinolones Market Revenues & Volume, By Clostridium Difficile Infections, 2021- 2031F |
6.2 Ireland Quinolones Market, By Pathogen Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Quinolones Market Revenues & Volume, By Gram-Positive Pathogen, 2021- 2031F |
6.2.3 Ireland Quinolones Market Revenues & Volume, By Gram-Negative Pathogen, 2021- 2031F |
6.3 Ireland Quinolones Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Ireland Quinolones Market Revenues & Volume, By Lomefloxacin, 2021- 2031F |
6.3.3 Ireland Quinolones Market Revenues & Volume, By Gatifloxacin, 2021- 2031F |
6.3.4 Ireland Quinolones Market Revenues & Volume, By Norfloxacin, 2021- 2031F |
6.3.5 Ireland Quinolones Market Revenues & Volume, By Moxifloxacin, 2021- 2031F |
6.3.6 Ireland Quinolones Market Revenues & Volume, By Ciprofloxacin, 2021- 2031F |
6.4 Ireland Quinolones Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Ireland Quinolones Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Ireland Quinolones Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5 Ireland Quinolones Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Ireland Quinolones Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Ireland Quinolones Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Ireland Quinolones Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6 Ireland Quinolones Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Ireland Quinolones Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Ireland Quinolones Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 Ireland Quinolones Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Ireland Quinolones Market Import-Export Trade Statistics |
7.1 Ireland Quinolones Market Export to Major Countries |
7.2 Ireland Quinolones Market Imports from Major Countries |
8 Ireland Quinolones Market Key Performance Indicators |
8.1 Number of new prescriptions of quinolones by healthcare providers |
8.2 Percentage increase in the adoption of quinolones in hospitals and clinics |
8.3 Patient satisfaction rates with quinolone treatments |
9 Ireland Quinolones Market - Opportunity Assessment |
9.1 Ireland Quinolones Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Ireland Quinolones Market Opportunity Assessment, By Pathogen Type, 2021 & 2031F |
9.3 Ireland Quinolones Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Ireland Quinolones Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Ireland Quinolones Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 Ireland Quinolones Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Quinolones Market - Competitive Landscape |
10.1 Ireland Quinolones Market Revenue Share, By Companies, 2024 |
10.2 Ireland Quinolones Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here